180 related articles for article (PubMed ID: 19412725)
21. Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.
Okubadejo NU; Rizig M; Ojo OO; Jonvik H; Oshinaike O; Brown E; Houlden H
PLoS One; 2018; 13(12):e0207984. PubMed ID: 30507963
[TBL] [Abstract][Full Text] [Related]
22. Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J
J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110
[TBL] [Abstract][Full Text] [Related]
23. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.
Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG
Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725
[TBL] [Abstract][Full Text] [Related]
24. Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia.
Saunders-Pullman R; Lipton RB; Senthil G; Katz M; Costan-Toth C; Derby C; Bressman S; Verghese J; Ozelius LJ
Neurosci Lett; 2006 Jul; 402(1-2):92-6. PubMed ID: 16632201
[TBL] [Abstract][Full Text] [Related]
25. G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia.
Pchelina SN; Yakimovskii AF; Ivanova ON; Emelianov AK; Zakharchuk AH; Schwarzman AL
Mov Disord; 2006 Dec; 21(12):2234-6. PubMed ID: 17044089
[TBL] [Abstract][Full Text] [Related]
26. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
[TBL] [Abstract][Full Text] [Related]
27. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.
Alcalay RN; Mejia-Santana H; Mirelman A; Saunders-Pullman R; Raymond D; Palmese C; Caccappolo E; Ozelius L; Orr-Urtreger A; Clark L; Giladi N; Bressman S; Marder K;
Parkinsonism Relat Disord; 2015 Feb; 21(2):106-10. PubMed ID: 25434972
[TBL] [Abstract][Full Text] [Related]
28. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.
Alcalay RN; Mejia-Santana H; Tang MX; Rosado L; Verbitsky M; Kisselev S; Ross BM; Louis ED; Comella CL; Colcher A; Jennings D; Nance MA; Bressman S; Scott WK; Tanner C; Mickel SF; Andrews HF; Waters CH; Fahn S; Cote LJ; Frucht SJ; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Caccappolo E; Ottman R; Clark LN; Marder KS
Arch Neurol; 2009 Dec; 66(12):1517-22. PubMed ID: 20008657
[TBL] [Abstract][Full Text] [Related]
29. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
Gan-Or Z; Giladi N; Rozovski U; Shifrin C; Rosner S; Gurevich T; Bar-Shira A; Orr-Urtreger A
Neurology; 2008 Jun; 70(24):2277-83. PubMed ID: 18434642
[TBL] [Abstract][Full Text] [Related]
30. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
31. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
[TBL] [Abstract][Full Text] [Related]
32. High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain).
Sierra M; González-Aramburu I; Sánchez-Juan P; Sánchez-Quintana C; Polo JM; Berciano J; Combarros O; Infante J
Mov Disord; 2011 Nov; 26(13):2343-6. PubMed ID: 21954089
[TBL] [Abstract][Full Text] [Related]
33. Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease.
Shanker V; Groves M; Heiman G; Palmese C; Saunders-Pullman R; Ozelius L; Raymond D; Bressman S
Mov Disord; 2011 Aug; 26(10):1875-80. PubMed ID: 21611978
[TBL] [Abstract][Full Text] [Related]
34. Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis.
Kim J; Daadi MM
Brain Res; 2019 Nov; 1722():146342. PubMed ID: 31330122
[TBL] [Abstract][Full Text] [Related]
35. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
36. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.
Ortega RA; Wang C; Raymond D; Bryant N; Scherzer CR; Thaler A; Alcalay RN; West AB; Mirelman A; Kuras Y; Marder KS; Giladi N; Ozelius LJ; Bressman SB; Saunders-Pullman R
JAMA Netw Open; 2021 Apr; 4(4):e215845. PubMed ID: 33881531
[TBL] [Abstract][Full Text] [Related]
37. The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews.
Dagan E; Schlesinger I; Ayoub M; Mory A; Nassar M; Kurolap A; Peretz-Aharon J; Gershoni-Baruch R
Parkinsonism Relat Disord; 2015 Sep; 21(9):1067-71. PubMed ID: 26169695
[TBL] [Abstract][Full Text] [Related]
38. Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene.
Mirelman A; Alcalay RN; Saunders-Pullman R; Yasinovsky K; Thaler A; Gurevich T; Mejia-Santana H; Raymond D; Gana-Weisz M; Bar-Shira A; Ozelius L; Clark L; Orr-Urtreger A; Bressman S; Marder K; Giladi N;
Mov Disord; 2015 Jun; 30(7):981-6. PubMed ID: 25809001
[TBL] [Abstract][Full Text] [Related]
39. Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers.
Thaler A; Mirelman A; Helmich RC; van Nuenen BF; Rosenberg-Katz K; Gurevich T; Orr-Urtreger A; Marder K; Bressman S; Bloem BR; Giladi N; Hendler T;
Cortex; 2013 Oct; 49(9):2501-11. PubMed ID: 23357204
[TBL] [Abstract][Full Text] [Related]
40. Absence of commonly reported leucine-rich repeat kinase 2 mutations in Eastern Indian Parkinson's disease patients.
Sanyal J; Sarkar B; Ojha S; Banerjee TK; Ray BC; Rao VR
Genet Test Mol Biomarkers; 2010 Oct; 14(5):691-4. PubMed ID: 20722494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
